<?xml version="1.0"?>

<document>
	<title>Thymidine-requiring Staphylococcus aureus [letter].</title>

	<author>Sparham-P-D.</author>
	<author>Lobban-D-I.</author>
	<author>Speller-D-C.</author>

	<source>Lancet. 1978 Jan 14. 1(8055). P 104-5.</source>

	<abstract>We confirm that thymidine-requiring (thy-) Staphylococcus aureus
   strains are common in patients with cystic fibrosis.  In 7 months, we
   isolated Staph. aureus from 11 of 14 patients with C.F.  Despite
   long-term co-trimoxazole Staph. aureus tends to persist in the sputum
   even though isolates do not require thymidine at first and are
   trimethoprim-sensitive in vitro.  Staph. aureus is less commonly
   isolated, and of less significance, in most other chest conditions
   for which co-trimoxazole is given.  These factors may explain why
   thy- staphylococci are recognised more frequently in C.F. than in
   other diseases.</abstract>

	<majorsubject>STAPHYLOCOCCUS-AUREUS: gd</majorsubject>
	<majorsubject>THYMIDINE</majorsubject>

	<minorsubject>CYSTIC-FIBROSIS: mi</minorsubject>
	<minorsubject>DRUG-RESISTANCE-MICROBIAL</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>TRIMETHOPRIM: ad</minorsubject>

	<reference>000   GEORGE RH             LANCET                           2  1081 977</reference>
	<reference>002   WILLIAMS RF           PROC EWGCF 6TH ANNU MTG                4 975</reference>

	<citation>1   WILLIAMS RF           CURR MED RES OPIN                6    43 979</citation>
	<citation>2   STURM AW              ANT V LEEUW J MICROBIOL SEROL   47    92 981</citation>
	<citation>3   LACEY RW              J MED MICROBIOL                 15   403 982</citation>
	<citation>4   KING CH               J CLIN MICROBIOL                18    79 983</citation>

</document>
